Peter Kirwan

4.5k citations
47 papers · 2.3k · 3 hit papers · h-index 16

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • HIV/AIDS Research and Interventions
    • SARS-CoV-2 detection and testing
    • COVID-19 epidemiological studies

Papers in

    • SARS-CoV-2 and COVID-19 Research 9
    • HIV/AIDS Research and Interventions 9
    • Tuberculosis Research and Epidemiology 4
    • HIV/AIDS drug development and treatment 3
    • Viral gastroenteritis research and epidemiology 2
    • COVID-19 Clinical Research Studies 2
    • HIV, Drug Use, Sexual Risk 3

Peter Kirwan

46 papers receiving 2.2k citations

Peter Kirwan's Hit Papers

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection 2022 · 493 citations
4930+1+3Years since publication100200300400500

Peers

Peter Kirwan
Comparison fields: 5 of 100
  • Infectious Diseases 1.5k
  • Modeling and Simulation 269
  • Health 352
  • Microbiology 70
  • Virology 51
Replace Kavitha Gajee with:
Kavitha Gajee United Kingdom
Michelle A. Barron United States
Martina Del Manso Italy
Varun K. Phadke United States
Bradley K. Ackerson United States
Diane F. Gbesemete United Kingdom
Katherine Adams United States
Houssein H. Ayoub Qatar
Kristin Goddard United States
Sarah A. Buchan Canada
Peter Kirwan relative to Kavitha Gajee United Kingdom Kavitha Gajee's profile →
Citations per field
00.5×2×4×6×8×
Kavitha Gajee · 1×
Citations per year

Countries citing papers authored by Peter Kirwan

Since Specialization
Citations

This map shows the geographic impact of Peter Kirwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kirwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kirwan more than expected).

Fields of papers citing papers by Peter Kirwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kirwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kirwan. The network helps show where Peter Kirwan may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Kirwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Kirwan Line = papers co-authored together Peter Kirwan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#Work
1
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
Hit paper breakdown →
2021577
2
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Hit paper breakdown →
2022493
3
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
Hit paper breakdown →
2021443
4 2016123
5 201783
6 202175
7 201853
8 201540
9 201728
10 202228
11 201827
12 202225
13 202023
14 202223
15 201819
16 202116
17 201915
18 202115
19 202115
20 202214

About Peter Kirwan

Peter Kirwan is a scholar working on Infectious Diseases, Epidemiology, Virology, Endocrinology and Hepatology, having authored 47 papers that have together received 2.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), HIV/AIDS Research and Interventions (9 papers), Tuberculosis Research and Epidemiology (4 papers), HIV/AIDS drug development and treatment (3 papers), HIV, Drug Use, Sexual Risk (3 papers), Viral gastroenteritis research and epidemiology (2 papers), COVID-19 Clinical Research Studies (2 papers) and Escherichia coli research studies (2 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Modeling and Simulation (269 citations), Health (352 citations), Microbiology (70 citations) and Virology (51 citations). Peter Kirwan has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Valérie Delpech, Alison E Brown, Sophie Grace Nash, Dana Ogaz, Sara Croxford, Daniela De Angelis, Nicky Connor, Gwenda Hughes, O Nöel Gill and Hamish P. Mohammed. Their work appears in journals such as HIV Medicine, Journal of Infection, Clinical Infectious Diseases, Sexually Transmitted Infections and AIDS Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact